Literature DB >> 27514498

Steroids can reduce warm ischemic reperfusion injury in a porcine donation after circulatory death model with ex vivo lung perfusion evaluation.

An Martens1,2, Marc Boada3, Bart M Vanaudenaerde2,4, Stijn E Verleden2,4, Robin Vos2,4, Geert M Verleden2,4, Eric K Verbeken5, Dirk Van Raemdonck2,3, Dominique Schols6, Sandra Claes6, Arne P Neyrinck7,8.   

Abstract

Donation after circulatory death (DCD) is being used to increase the number of transplantable organs. The role and timing of steroids in DCD donation and ex vivo lung perfusion (EVLP) has not been thoroughly investigated. In this study, we investigated the effect of steroids on warm ischemic injury in a porcine model (n = 6/group). Following cardiac arrest, grafts were left untouched in the donor (90-min warm ischemia). Graft function was assessed after 6 h of EVLP. In the MP group, 500 mg methylprednisolone was given prior to cardiac arrest and during EVLP. In the CONTR group, no steroids were added. Median lung compliance (13 ml/cmH2 0) was significantly better preserved in the CONTR group than in the MP group (30.5 ml/cmH2 0). Also, median wet-to-dry weight (6.11 vs. 6.94) and CT density (182.5 vs. 352.9 g/l) were significantly better in the MP group than in the CONTR group, respectively. There was no difference in oxygenation and pulmonary vascular resistance. Perfusate cytokine analysis showed a significant reduction in IL-1β, IL-8, IFN-α, IL-10, TNF-α, and IFN-γ in MP. Cytokines in bronchoalveolar lavage were not decreased except for IFN-gamma. We demonstrated that warm ischemic injury in DCD donation can be attenuated by steroids when given prior to warm ischemia and during EVLP. Ethical context of donor preconditioning should be discussed further.
© 2016 Steunstichting ESOT.

Entities:  

Keywords:  animal models; donation; donation after circulatory death; donor management; ex vivo lung perfusion; experimental transplantation; extended donor pool; ischemia reperfusion injury; organ preservation and procurement

Mesh:

Substances:

Year:  2016        PMID: 27514498     DOI: 10.1111/tri.12823

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  22 in total

Review 1.  Lung transplantation, ex-vivo reconditioning and regeneration: state of the art and perspectives.

Authors:  Lorenzo Rosso; Alberto Zanella; Ilaria Righi; Mario Barilani; Lorenza Lazzari; Eleonora Scotti; Francesca Gori; Paolo Mendogni
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 2.  Primary graft dysfunction: pathophysiology to guide new preventive therapies.

Authors:  Ciara M Shaver; Lorraine B Ware
Journal:  Expert Rev Respir Med       Date:  2017-01-20       Impact factor: 3.772

Review 3.  Organ preservation: from the past to the future.

Authors:  Lei Jing; Leeann Yao; Michael Zhao; Li-Ping Peng; Mingyao Liu
Journal:  Acta Pharmacol Sin       Date:  2018-03-22       Impact factor: 6.150

Review 4.  Donors after cardiocirculatory death and lung transplantation.

Authors:  Ilhan Inci
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 5.  Sterile inflammation in thoracic transplantation.

Authors:  C Corbin Frye; Amit I Bery; Daniel Kreisel; Hrishikesh S Kulkarni
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

6.  Ex Vivo Perfusion With Methylprednisolone Attenuates Brain Death-induced Lung Injury in Rats.

Authors:  Judith E van Zanden; Henri G D Leuvenink; Erik A M Verschuuren; Zwanida J Veldhuis; Petra J Ottens; Michiel E Erasmus; Maximilia C Hottenrott
Journal:  Transplant Direct       Date:  2021-03-16

7.  A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury.

Authors:  An Martens; Sofie Ordies; Bart M Vanaudenaerde; Stijn E Verleden; Robin Vos; Geert M Verleden; Eric K Verbeken; Dirk E Van Raemdonck; Sandra Claes; Dominique Schols; Matthieu Chalopin; Ira Katz; Geraldine Farjot; Arne P Neyrinck
Journal:  Med Gas Res       Date:  2017-03-30

8.  Pyrrolidine dithiocarbamate administered during ex-vivo lung perfusion promotes rehabilitation of injured donor rat lungs obtained after prolonged warm ischemia.

Authors:  Cyril Francioli; Xingyu Wang; Roumen Parapanov; Etienne Abdelnour; Jérôme Lugrin; Fabrizio Gronchi; Jean Perentes; Philippe Eckert; Hans-Beat Ris; Lise Piquilloud; Thorsten Krueger; Lucas Liaudet
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

9.  Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model.

Authors:  An Martens; Sofie Ordies; Bart M Vanaudenaerde; Stijn E Verleden; Robin Vos; Dirk E Van Raemdonck; Geert M Verleden; Valerie D Roobrouck; Sandra Claes; Dominique Schols; Eric Verbeken; Catherine M Verfaillie; Arne P Neyrinck
Journal:  Stem Cell Res Ther       Date:  2017-07-05       Impact factor: 6.832

Review 10.  The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.

Authors:  Jasper Iske; Christopher A Hinze; Jawad Salman; Axel Haverich; Stefan G Tullius; Fabio Ius
Journal:  Am J Transplant       Date:  2021-08-24       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.